期刊文献+

肺炎克雷伯杆菌对头孢菌素类抗生素耐药机制的研究 被引量:18

Study on the cephalosporins resistant to clinic isolates of Klebsiella pneumoniae
暂未订购
导出
摘要 目的:研究四川大学华西医院自2003年9月~2004年3月间分离的18株肺炎克雷伯杆菌对头孢菌素的耐药性及其机制,以指导临床合理使用抗生素.方法:收集、分离及鉴定肺炎克雷伯杆菌,用琼脂二倍稀释法及纸片扩散法测定临床分离肺炎克雷伯杆菌对6种抗菌药物的MIC值;头孢硝噻吩纸片法定性筛选细菌的β-内酰胺酶;通过NCCLS2004年版推荐的纸片扩散法初筛ESBLs;酶提取物三维实验检测高产AmpC酶的肺炎克雷伯杆菌.结果:从四川大学华西医院分离的18株肺炎克雷伯杆菌对头孢吡肟的耐药率为11.1%,对三代头孢菌素的耐药率都达到了22.2%~44.4%;18株实验菌中有11株产β-内酰胺酶,其中有9株产ESBLs和1株产AmpC酶.结论:产生β-内酰胺酶是肺炎克雷伯杆菌对头孢菌素类抗生素耐药的机制之一. Object: Study on the resistant rates and resistance mechanisms of Klebsiella pneumoniae to cephalosporins isolated from West China hospital. Methods: After Klebsiella pneumoniae was collected,isolated and identified, a bacterial susceptibility test was examined by agar dilution method and the standard disk diffusion method, Nitrocefin method was used to screen of β-1actamase, a disc diffusion confirmatory test was used to detect ESBLs-producing strains as described in NCCLS2004, and three-dimensional test was used to detect strains which continuously producing high AmpC β-1actamase. Results: The resistant rate of the 18 strains Klebsiella pneumoniae to cefepime were 11.1% and 22.2% respectively, but the resistant rates to third generation cephalosporins was all higher from 22.2% to 66.7% ; 11 strains produced β-1actamase including 9 strains producing ESBLs and 1 strain producing AmpC enzyme. Conclusions: Production of β-lactamase is one of the resistance mechanisms of Klebsiella pneumoniae to cephalosporins.
出处 《四川生理科学杂志》 2006年第1期20-23,共4页 Sichuan Journal of Physiological Sciences
关键词 肺炎克雷伯杆菌 耐药机制 Β-内酰胺酶 Klebsiella pneumoniae β-lactamase resistance mechanisms
  • 相关文献

参考文献6

二级参考文献24

  • 1徐英春,谢秀丽,张小江,张悦贤,王澎,陈民钧.头孢米诺和其他14种抗菌药物对产与不产超广谱β-内酰胺酶菌株抗菌活性比较[J].中华医院感染学杂志,2004,14(7):727-729. 被引量:39
  • 2普珍,高山,刘小康.肺炎克雷伯杆菌对头孢菌素类抗生素耐药机制的研究[J].四川生理科学杂志,2006,28(1):20-23. 被引量:18
  • 3王选锭,应可净,刘富光,李尚贤,金祖武,卞如濂.头孢西丁与头孢美唑随机对照治疗细菌性感染124例临床评价[J].中国临床药理学杂志,1996,12(4):193-199. 被引量:15
  • 4[1]Philip E, Coudron E S, Thomson K S. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center [J]. J Chin Microbiol,2000,38(5):1791
  • 5[4]National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing.9th informational supplemented.Wayne PA:National Committee for Clinical Laboratory Standards,1999,19:36
  • 6[5]Bush K,Jacoky GA,Medeiros AA.A functional classification scheme for B-lactamase and its correlation with molecular structure Antimicrob Agents Chemother,1995,39:1211.
  • 7[7]Jacoby GA,Han P.Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli.J Clin Microbiol,1996,34(4):908 ~911.
  • 8[10]Jacoby GA,Medeireos AA.More extended2spectrum beta-lactamases.Antimicrob Agents Chemother,1991,35:1697 ~ 1704.
  • 9许锦民,中华医学检验杂志,1998年,21卷,373页
  • 10M. T. Nüesch-Inderbinen,H. H?chler,F. H. Kayser. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test[J] 1996,European Journal of Clinical Microbiology & Infectious Diseases(5):398~402

共引文献220

同被引文献104

引证文献18

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部